CHEOY:OTCMKTS
Cochlear
US$ 44,72
arrow_downward
-0,07%(-0,030) 1D
15 okt, 16:00:00 GMT-4 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor CHEOY genereren…
Openen
US$ 44,61
Hoog
US$ 44,82
Laag
US$ 44,60
Beursw.
8,49 mld.
Gem. vol.
18,50K
Volume
26,66K
52 wk hoog
US$ 98,49
52 wk laag
US$ 31,82
Bèta
0,68
Uitstaande aandelen
130,80 mln.
Aantal medewerkers
5K
Openen
US$ 44,61
Hoog
US$ 44,82
Laag
US$ 44,60
Beursw.
8,49 mld.
Gem. vol.
18,50K
Volume
26,66K
52 wk hoog
US$ 98,49
52 wk laag
US$ 31,82
Bèta
0,68
Uitstaande aandelen
130,80 mln.
Aantal medewerkers
5K
Nieuwsartikelen
Van webbronnen en nieuwspartners
ad-hoc-news.de
·
3 uur geleden
UBS keeps AUD 135.00 target for Cochlear stock
Simply Wall Street
·
4 uur geleden
Cochlear And 2 Australian Healthcare Stocks To Watch
PR Newswire
·
1 dag geleden
Cochlear Named #1 Most Trustworthy Healthcare Company In The World For 2026
Profiel
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
Over Cochlear
CEODig Howitt
Medewerkers5,4K
Opgericht1981
HoofdkantoorSydney, Nieuw-Zuid-Wales, Australië
Sector-
Websitecochlear.com